Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Kennedy sets out views on NICE’s future

May 14, 2009 Research and Development NICE

Two stakeholder workshops which could shape NICE's future direction are to be held next week. Professor Sir Ian Kennedy has …
News

AstraZeneca buoyed as Brilinta tops Plavix in trial

May 13, 2009 Research and Development, Sales and Marketing AZ, Brillinta

AstraZeneca has been lifted by clinical results indicating its antiplatelet drug Brilinta outperformed Sanofi-Aventis/Bristol-Myers Squibb’s Plavix – currently the world’s …
News

UK a step closer to new swine flu vaccine

May 11, 2009 Research and Development NHS, h1n1

The first step towards producing a European prototype of a swine flu vaccine has been achieved by the UK's Health …
News

GSK claims superiority for Cervarix in head-to-head trial

May 11, 2009 Research and Development, Sales and Marketing GSK, vaccines

GlaxoSmithKline says a new study shows its cervical cancer vaccine Cervarix induces a higher immune response compared to rival Gardasil. …
News

Cmed and Tessella join forces on adaptive trials

May 11, 2009 Research and Development Cmed, digi

UK contract research organisation Cmed Research has bolstered its ability to carry out adaptive clinical trials on behalf of clients …
News

Pharma must go further with its collaborations

May 8, 2009 Research and Development, Sales and Marketing pwC, strategy

Pharma companies will soon have to start collaborating with companies outside the healthcare sector.The global economic situation will make this …
News

Servier signs drug discovery deal with Vernalis

May 7, 2009 Research and Development, Sales and Marketing Servier, Vernalis

Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …
News

NICE rejects Nexavar for liver cancer

May 7, 2009 Research and Development, Sales and Marketing Bayer, NICE, Nexavar

NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …
News

Novo Nordisk plans summer launches for new diabetes drug

May 7, 2009 Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes

Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …
News

NHS should be ‘jewel in the crown’ for UK biotech

May 7, 2009 Research and Development NICE

The NHS could be the 'jewel in the crown' of UK medical research, if it would only assist in clinical …
News

Bayer Schering’s contraceptive patch enters phase III

May 5, 2009 Research and Development, Sales and Marketing Bayer, sexual health

Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …
News

Coast first casualty in US overhaul of IRB system

May 5, 2009 Research and Development FDA, US

A US company offering institutional review board services to sponsors of clinical trials has been forced to close its doors …
News

Biotech partnering in the credit crunch

May 1, 2009 Research and Development biotech, partnering, pharma

Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …
Feature

Avastin fails in colon cancer study

April 30, 2009 Research and Development Cancer, Roche

Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …
News

Sanofi makes cuts to phase III pipeline

April 30, 2009 Research and Development Sanofi-Aventis

Sanofi-Aventis has suspended development of four late-stage drugs and ten other projects following an R&D review. The decision was announced …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026